Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Inventory Average (2019 - 2025)

Coherus Oncology's Inventory Average history spans 6 years, with the latest figure at $2.6 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 89.93% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, down 89.93%, while the annual FY2025 figure was $3.7 million, 88.96% down from the prior year.
  • Inventory Average for Q4 2025 was $2.6 million at Coherus Oncology, down from $3.3 million in the prior quarter.
  • Across five years, Inventory Average topped out at $54.9 million in Q3 2024 and bottomed at $2.6 million in Q4 2025.
  • The 4-year median for Inventory Average is $25.9 million (2024), against an average of $23.1 million.
  • The largest annual shift saw Inventory Average dropped 5.35% in 2021 before it plummeted 94.02% in 2025.
  • A 4-year view of Inventory Average shows it stood at $37.6 million in 2021, then fell by 0.85% to $37.3 million in 2022, then plummeted by 30.49% to $25.9 million in 2024, then plummeted by 89.93% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for CHRS's Inventory Average are $2.6 million (Q4 2025), $3.3 million (Q3 2025), and $4.0 million (Q2 2025).